Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 68788-8752

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 68788-8752). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure (Venlafaxine Fig1)

Figure (Venlafaxine Fig1)
This information appears to be about special populations with hepatic and renal impairments, CYP206 polymorphism, age, and gender considerations during a study involving Velatarie. The study seems to include different categories related to hepatic and renal impairments, including mild and moderate levels, as well as hemodialysis. The presence of CYP206 polymorphism and the distinction between poor/extensive metabolizers are noted. Additionally, the study might be exploring the impact of age over 60 years and gender differences in the context of Velatarie. The text also mentions "Fold Change and 90% CI" which could indicate the analysis of results or changes observed in the study.*
FDA Label Image

Figure (Venlafaxine Fig2)

Figure (Venlafaxine Fig2)
This text appears to list different interacting drugs, including Enanol, Diazepam, Cimetidine, Ketoconazole, Indinavir, Metoprolol, and Lithium. It mentions PK Fold Change and 90% CI values for these drugs and seems to be related to changes relative to a reference value. The document provides information that can potentially be used to understand and analyze the effects of these drugs on pharmacokinetics.*
FDA Label Image

Figure (Venlafaxine Fig3)

Figure (Venlafaxine Fig3)
This text lists various drugs and their interactions with ethanol, including Aprazolam, Indinavir, Metoprolal, Risperidone, Haloperidol, Caffeine, Tolbutamide, and Lithium. It also mentions different analytes like Diazepam, Desmetyldiazepam, Alprazolam, Metaprolol, Imipramine, Desipramine, and Haloperidol. Additionally, it provides information on peak concentration (Cmax) and area under the curve (AU) for these drugs when interacting with ethanol, along with fold change and 90% confidence interval. The data seems to be related to pharmacokinetics and drug interactions.*
FDA Label Image

Venlafaxine HCl Extended-release Capsules Usp 150mg (Venlafaxine Fig8)

Venlafaxine HCl Extended-release Capsules Usp 150mg (Venlafaxine Fig8)
This is a description of Venlafaxine HCI Extended-Release Capsules, USP 150mg, a generic version of Effexor ER. The package contains extended-release capsules each with 150mg of Venlafaxine hydrochloride. The product is manufactured by Aurobindo Pharma Limited. The warning indicates storage temperature requirements. It is important to note that federal law prohibits transferring the drug to anyone other than the prescribed patient. The text includes some instructions in Spanish and details for billing and patient information.*
FDA Label Image

Chemical Structure (Venlafaxine Str)

Chemical Structure (Venlafaxine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.